0000006281--10-282023Q1FALSE00000062812022-10-302023-01-2800000062812023-01-28xbrli:sharesiso4217:USD00000062812021-10-312022-01-29iso4217:USDxbrli:shares00000062812022-10-290000006281us-gaap:CommonStockMember2022-10-290000006281us-gaap:AdditionalPaidInCapitalMember2022-10-290000006281us-gaap:RetainedEarningsMember2022-10-290000006281us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-10-290000006281us-gaap:RetainedEarningsMember2022-10-302023-01-280000006281us-gaap:CommonStockMember2022-10-302023-01-280000006281us-gaap:AdditionalPaidInCapitalMember2022-10-302023-01-280000006281us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-10-302023-01-280000006281us-gaap:CommonStockMember2023-01-280000006281us-gaap:AdditionalPaidInCapitalMember2023-01-280000006281us-gaap:RetainedEarningsMember2023-01-280000006281us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-280000006281us-gaap:CommonStockMember2021-10-300000006281us-gaap:AdditionalPaidInCapitalMember2021-10-300000006281us-gaap:RetainedEarningsMember2021-10-300000006281us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-10-300000006281us-gaap:RetainedEarningsMember2021-10-312022-01-290000006281us-gaap:CommonStockMember2021-10-312022-01-290000006281us-gaap:AdditionalPaidInCapitalMember2021-10-312022-01-290000006281us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-10-312022-01-290000006281us-gaap:CommonStockMember2022-01-290000006281us-gaap:AdditionalPaidInCapitalMember2022-01-290000006281us-gaap:RetainedEarningsMember2022-01-290000006281us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-2900000062812021-10-3000000062812022-01-290000006281us-gaap:AccumulatedTranslationAdjustmentMember2022-10-290000006281us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-10-290000006281us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-10-290000006281us-gaap:AccumulatedTranslationAdjustmentMember2022-10-302023-01-280000006281us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-10-302023-01-280000006281us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-10-302023-01-280000006281us-gaap:AccumulatedTranslationAdjustmentMember2023-01-280000006281us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-280000006281us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-280000006281us-gaap:ForeignExchangeContractMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-10-302023-01-280000006281us-gaap:ForeignExchangeContractMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-10-312022-01-290000006281us-gaap:InterestRateContractMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-10-302023-01-280000006281us-gaap:InterestRateContractMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-10-312022-01-290000006281us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-10-302023-01-280000006281us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-10-312022-01-290000006281us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-10-302023-01-280000006281us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-10-312022-01-290000006281us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-10-302023-01-280000006281us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-10-312022-01-290000006281adi:GlobalRepositioningActionsMember2022-10-290000006281adi:GlobalRepositioningActionsMember2022-10-302023-01-280000006281adi:GlobalRepositioningActionsMember2023-01-280000006281adi:IndustrialMember2022-10-302023-01-28xbrli:pure0000006281adi:IndustrialMember2021-10-312022-01-290000006281adi:AutomotiveMember2022-10-302023-01-280000006281adi:AutomotiveMember2021-10-312022-01-290000006281adi:CommunicationsMember2022-10-302023-01-280000006281adi:CommunicationsMember2021-10-312022-01-290000006281adi:ConsumerMember2022-10-302023-01-280000006281adi:ConsumerMember2021-10-312022-01-290000006281us-gaap:SalesChannelThroughIntermediaryMember2022-10-302023-01-280000006281us-gaap:SalesChannelThroughIntermediaryMember2021-10-312022-01-290000006281us-gaap:SalesChannelDirectlyToConsumerMember2022-10-302023-01-280000006281us-gaap:SalesChannelDirectlyToConsumerMember2021-10-312022-01-290000006281adi:SalesChannelOtherMember2022-10-302023-01-280000006281adi:SalesChannelOtherMember2021-10-312022-01-290000006281us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-01-280000006281us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-01-280000006281us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-01-280000006281us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-01-280000006281us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-01-280000006281us-gaap:FairValueMeasurementsRecurringMember2023-01-280000006281us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-10-290000006281us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-10-290000006281us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-10-290000006281us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-10-290000006281us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-10-290000006281us-gaap:FairValueMeasurementsRecurringMember2022-10-290000006281adi:NotesDueOctober2024Memberus-gaap:SeniorNotesMember2023-01-280000006281adi:NotesDueOctober2024Memberus-gaap:SeniorNotesMember2022-10-290000006281adi:NotesDueApril2025Memberus-gaap:SeniorNotesMember2023-01-280000006281adi:NotesDueApril2025Memberus-gaap:SeniorNotesMember2022-10-290000006281adi:NotesDueDecember2026Memberus-gaap:SeniorNotesMember2023-01-280000006281adi:NotesDueDecember2026Memberus-gaap:SeniorNotesMember2022-10-290000006281adi:MaximMemberadi:NotesDueJune2027Memberus-gaap:SeniorNotesMember2023-01-280000006281adi:MaximMemberadi:NotesDueJune2027Memberus-gaap:SeniorNotesMember2022-10-290000006281adi:NotesDueJune2027Memberus-gaap:SeniorNotesMember2023-01-280000006281adi:NotesDueJune2027Memberus-gaap:SeniorNotesMember2022-10-290000006281adi:NotesDueOctober2028Memberus-gaap:SeniorNotesMember2023-01-280000006281adi:NotesDueOctober2028Memberus-gaap:SeniorNotesMember2022-10-290000006281adi:NotesDueOctober2031Memberus-gaap:SeniorNotesMember2023-01-280000006281adi:NotesDueOctober2031Memberus-gaap:SeniorNotesMember2022-10-290000006281adi:NotesDueOctober2032Memberus-gaap:SeniorNotesMember2023-01-280000006281adi:NotesDueOctober2032Memberus-gaap:SeniorNotesMember2022-10-290000006281adi:NotesDueDecember2036Memberus-gaap:SeniorNotesMember2023-01-280000006281adi:NotesDueDecember2036Memberus-gaap:SeniorNotesMember2022-10-290000006281adi:NotesDueOctober2041Memberus-gaap:SeniorNotesMember2023-01-280000006281adi:NotesDueOctober2041Memberus-gaap:SeniorNotesMember2022-10-290000006281adi:NotesDueDecember2045Memberus-gaap:SeniorNotesMember2023-01-280000006281adi:NotesDueDecember2045Memberus-gaap:SeniorNotesMember2022-10-290000006281adi:NotesDueOctober2051Memberus-gaap:SeniorNotesMember2023-01-280000006281adi:NotesDueOctober2051Memberus-gaap:SeniorNotesMember2022-10-290000006281us-gaap:ForwardContractsMember2023-01-280000006281us-gaap:ForwardContractsMember2022-10-290000006281us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-01-280000006281us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2022-10-290000006281us-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMember2023-01-280000006281us-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMember2022-10-290000006281adi:NotesDueOctober2031Memberus-gaap:InterestRateSwapMemberus-gaap:SeniorNotesMember2023-01-280000006281adi:NotesDueOctober2031Memberus-gaap:InterestRateSwapMember2023-01-280000006281adi:AccruedLiabilitiesCurrentMemberus-gaap:InterestRateSwapMember2022-10-302023-01-280000006281adi:UnsecuredLongTermDebtNoncurrentMemberus-gaap:InterestRateSwapMember2022-10-302023-01-280000006281us-gaap:RevolvingCreditFacilityMember2021-06-232021-06-230000006281us-gaap:RevolvingCreditFacilityMember2021-06-230000006281us-gaap:RevolvingCreditFacilityMember2022-10-302023-01-280000006281us-gaap:RevolvingCreditFacilityMemberadi:SecuredOvernightFinancingRateSOFRMembersrt:MinimumMember2022-10-302023-01-280000006281srt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberadi:SecuredOvernightFinancingRateSOFRMember2022-10-302023-01-280000006281us-gaap:RevolvingCreditFacilityMember2023-01-280000006281adi:MaximIntegratedProductsIncMemberus-gaap:SettlementWithTaxingAuthorityMember2023-01-280000006281us-gaap:CommonStockMemberus-gaap:SubsequentEventMember2023-02-142023-02-14

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 10-Q

(Mark One)

☑			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended January 28, 2023

    OR

☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from             to             

Commission File No. 1-7819

Analog Devices, Inc.

(Exact name of registrant as specified in its charter) 

Massachusetts

04-2348234

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

One Analog Way,

Wilmington,

MA

01887

(Address of principal executive offices)

(Zip Code)

(781) 935-5565

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock $0.16 2/3 par value per share			ADI			Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☑    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☑    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☑

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ☐    No  ☑

As of January 28, 2023 there were 505,852,499 shares of common stock of the registrant, $0.16 2/3 par value per share, outstanding.

---

PART I - FINANCIAL INFORMATION

 

ITEM 1.			Financial Statements

ANALOG DEVICES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(in thousands, except per share amounts)

			Three Months Ended
			January 28, 2023						January 29, 2022
Revenue			$	3,249,630					$	2,684,293
Cost of sales			1,125,289						1,282,296
Gross margin			2,124,341						1,401,997
Operating expenses:
Research and development			414,095						426,780
Selling, marketing, general and administrative			326,284						297,365
Amortization of intangibles			253,142						253,367
Special charges, net			—						59,728
Total operating expenses			993,521						1,037,240
Operating income:			1,130,820						364,757
Nonoperating expense (income):
Interest expense			60,453						51,964
Interest income			(10,829)						(218)
Other, net			7,723						(10,544)
Total nonoperating expense (income)			57,347						41,202
Income before income taxes			1,073,473						323,555
Provision for income taxes			111,999						43,478
Net income			$	961,474					$	280,077
Shares used to compute earnings per common share – basic			507,121						525,291
Shares used to compute earnings per common share – diluted			511,184						530,142
Basic earnings per common share			$	1.90					$	0.53
Diluted earnings per common share			$	1.88					$	0.53

See accompanying notes.

1

---

ANALOG DEVICES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

(in thousands)

			Three Months Ended
			January 28, 2023						January 29, 2022
Net income			$	961,474					$	280,077
Foreign currency translation adjustments			2,499						(4,603)
Change in fair value of derivative instruments designated as cash flow hedges, net			25,467						1,046
Changes in pension plans, net actuarial gain/loss and foreign currency translation adjustments, net			452						1,504
Other comprehensive income (loss)			28,418						(2,053)
Comprehensive income			$	989,892					$	278,024

See accompanying notes.

2

---

ANALOG DEVICES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in thousands, except share and per share amounts)

			January 28, 2023						October 29, 2022
ASSETS
Current Assets
Cash and cash equivalents			$	1,670,462					$	1,470,572
Accounts receivable			1,629,870						1,800,462
Inventories			1,522,942						1,399,914
Prepaid expenses and other current assets			338,226						267,044
Total current assets			5,161,500						4,937,992
Non-current Assets
Net property, plant and equipment			2,524,655						2,401,304
Goodwill			26,913,134						26,913,134
Intangible assets, net			12,763,229						13,265,406
Deferred tax assets			2,267,178						2,264,888
Other assets			604,824						519,626
Total non-current assets			45,073,020						45,364,358
TOTAL ASSETS			$	50,234,520					$	50,302,350
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
Accounts payable			$	534,659					$	582,160
Income taxes payable			513,943						265,845
Accrued liabilities			1,385,075						1,594,650
Total current liabilities			2,433,677						2,442,655
Non-current Liabilities
Long-term debt			6,543,250						6,548,625
Deferred income taxes			3,477,044						3,622,538
Income taxes payable			712,376						707,846
Other non-current liabilities			536,688						515,363
Total non-current liabilities			11,269,358						11,394,372
Shareholders’ Equity
Preferred stock, $1.00 par value, 471,934 shares authorized, none outstanding			—						—
Common stock, $0.16 2/3 par value, 1,200,000,000 shares authorized, 505,852,499 shares outstanding (509,295,941 on October 29, 2022)			84,306						84,880
Capital in excess of par value			27,319,566						27,857,270
Retained earnings			9,297,347						8,721,325
Accumulated other comprehensive loss			(169,734)						(198,152)
Total shareholders’ equity			36,531,485						36,465,323
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY			$	50,234,520					$	50,302,350

See accompanying notes.

3

---

ANALOG DEVICES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

(Unaudited)

(in thousands)

			Three Months Ended January 28, 2023
															Capital in												Accumulated Other
			Common Stock												Excess of						Retained						Comprehensive
			Shares						Amount						Par Value						Earnings						Loss
BALANCE, OCTOBER 29, 2022			509,296						$	84,880					$	27,857,270					$	8,721,325					$	(198,152)
Net income																					961,474
Dividends declared and paid - $0.76 per share																					(385,452)
Issuance of stock under stock plans and other			617						103						41,135
Stock-based compensation expense															75,041
Other comprehensive income																											28,418
Common stock repurchased			(4,061)						(677)						(653,880)
BALANCE, JANUARY 28, 2023			505,852						$	84,306					$	27,319,566					$	9,297,347					$	(169,734)

			Three Months Ended January 29, 2022
															Capital in												Accumulated Other
			Common Stock												Excess of						Retained						Comprehensive
			Shares						Amount						Par Value						Earnings						Loss
BALANCE, OCTOBER 30, 2021			525,331						$	87,554					$	30,574,237					$	7,517,316					$	(186,565)
Net income																					280,077
Dividends declared and paid - $0.69 per share																					(362,645)
Issuance of stock under stock plans and other			579						100						8,371
Stock-based compensation expense															86,939
Other comprehensive loss																											(2,053)
Common stock repurchased			(2,595)						(433)						(575,586)
BALANCE, JANUARY 29, 2022			523,315						$	87,221					$	30,093,961					$	7,434,748					$	(188,618)

See accompanying notes.

4

---

ANALOG DEVICES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(in thousands)

			Three Months Ended
			January 28, 2023						January 29, 2022
Cash flows from operating activities:
Net income			$	961,474					$	280,077
Adjustments to reconcile net income to net cash provided by operations:
Depreciation			85,321						65,165
Amortization of intangibles			502,177						504,645
Cost of goods sold for inventory acquired			—						271,396
Stock-based compensation expense			75,041						86,939
Deferred income taxes			(146,354)						(34,651)
Non-cash operating lease costs			(2,646)						7,823
Other			12,378						(9,571)
Changes in operating assets and liabilities			(81,086)						(315,410)
Total adjustments			444,831						576,336
Net cash provided by operating activities			1,406,305						856,413
Cash flows from investing activities:
Additions to property, plant and equipment			(176,158)						(111,133)
Other			102						7,824
Net cash used for investing activities			(176,056)						(103,309)
Cash flows from financing activities:
Early termination of debt			—						(519,116)
Dividend payments to shareholders			(385,452)						(362,645)
Repurchase of common stock			(654,557)						(76,019)
Proceeds from employee stock plans			41,238						8,471
Other			(31,588)						12,041
Net cash used for financing activities			(1,030,359)						(937,268)
Effect of exchange rate changes on cash			—						(3,401)
Net increase (decrease) in cash and cash equivalents			199,890						(187,565)
Cash and cash equivalents at beginning of period			1,470,572						1,977,964
Cash and cash equivalents at end of period			$	1,670,462					$	1,790,399

See accompanying notes.

5

---

ANALOG DEVICES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED JANUARY 28, 2023 (UNAUDITED)

(all tabular amounts in thousands except per share amounts and percentages)

Note 1 – Basis of Presentation

In the opinion of management, the information furnished in the accompanying condensed consolidated financial statements reflects all normal recurring adjustments that are necessary to fairly state the results for these interim periods and should be read in conjunction with Analog Devices, Inc.’s (the Company) Annual Report on Form 10-K for the fiscal year ended October 29, 2022 (fiscal 2022) and related notes. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for the fiscal year ending October 28, 2023 (fiscal 2023) or any future period.

The Company has a 52-53 week fiscal year that ends on the Saturday closest to the last day in October. Certain amounts reported in previous periods have been reclassified to conform to the fiscal 2023 presentation.

Note 2 – Shareholders' Equity

As of January 28, 2023, the Company had repurchased a total of approximately 193.6 million shares of its common stock for approximately $12.4 billion under the Company's share repurchase program. As of January 28, 2023, an additional $4.3 billion remains available for repurchase of shares under the current authorized program. The Company also repurchases shares in settlement of employee tax withholding obligations due upon the vesting of restricted stock units/awards or the exercise of stock options as well as for the Company's employee stock purchase plan. Future repurchases of common stock will be dependent upon the Company's financial position, results of operations, outlook, liquidity and other factors deemed relevant by the Company.

Note 3 – Accumulated Other Comprehensive (Loss) Income

The following table provides the changes in accumulated other comprehensive (loss) income (AOCI) by component and the related tax effects during the first three months of fiscal 2023.

			Foreign currency translation adjustment																		Unrealized holding gains (losses) on derivatives						Pension plans						Total
October 29, 2022			$	(72,136)																	$	(119,613)					$	(6,403)					$	(198,152)
Other comprehensive income before reclassifications			2,499																		28,211						82						30,792
Amounts reclassified out of other comprehensive income			—																		924						370						1,294
Tax effects			—																		(3,668)						—						(3,668)
Other comprehensive income			2,499																		25,467						452						28,418
January 28, 2023			$	(69,637)																	$	(94,146)					$	(5,951)					$	(169,734)

The amounts reclassified out of AOCI into the Condensed Consolidated Statements of Income and the Condensed Consolidated Statements of Shareholders' Equity with presentation location during each period were as follows:

6

---

						Three Months Ended
Comprehensive (Loss) Income Component						January 28, 2023						January 29, 2022																		Location
Unrealized holding (gains) losses on derivatives:
Currency forwards						$	(1,059)					$	1,751																	Cost of sales
						(447)						1,210																		Research and development
						(1,297)						1,873																		Selling, marketing, general and administrative
Interest rate derivatives						3,727						3,731																		Interest expense
						924						8,565																		Total before tax
						(802)						(1,301)																		Tax
						$	122					$	7,264																	Net of tax
Amortization of pension components included in the computation of net periodic pension cost:
Actuarial losses						$	370					$	489																	Net of tax
Total amounts reclassified out of AOCI, net of tax						$	492					$	7,753

Note 4 – Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share:

			Three Months Ended
			January 28, 2023						January 29, 2022
Net Income			$	961,474					$	280,077
Basic shares:
Weighted-average shares outstanding			507,121						525,291
Earnings per common share basic:			$	1.90					$	0.53
Diluted shares:
Weighted-average shares outstanding			507,121						525,291
Assumed exercise of common stock equivalents			4,063						4,851
Weighted-average common and common equivalent shares			511,184						530,142
Earnings per common share diluted:			$	1.88					$	0.53
Anti-dilutive shares related to:
Outstanding stock-based awards			322						185

Note 5 – Special Charges, Net

Liabilities related to special charges, net are included in Accrued liabilities in the Condensed Consolidated Balance Sheets. The activity is detailed below:

Accrued Special Charges																					Global Repositioning Actions
Balance at October 29, 2022																					$	52,070
Severance and benefit payments																					(16,298)
Balance at January 28, 2023																					$	35,772

7

---

Note 6 - Commitments and Contingencies

On March 17, 2022, Walter E. Ryan and Ryan Asset Management, LLC, purported stockholders of Maxim Integrated Products, Inc. (Maxim), filed a putative class action in the Court of Chancery of the State of Delaware (C.A. No. 2022—0255) against the Company and the former directors of Maxim. The complaint alleges breach of fiduciary duties by the individual defendants in connection with Maxim’s agreement, as part of the merger negotiations with the Company, to suspend Maxim dividends for up to four quarters prior to the closing of the Company's acquisition of Maxim. The complaint further alleges that the Company aided and abetted that alleged breach of fiduciary duties. The plaintiffs seek damages in an amount to be determined at trial, plaintiffs’ costs and disbursements, including reasonable attorneys’ and experts’ fees, costs and other expenses. The Company believes that it and the other defendants have meritorious defenses to these allegations; however, the Company is currently unable to determine the ultimate outcome of this matter or determine an estimate, or a range of estimates, of potential losses, if any.

Note 7 – Revenue

Revenue Trends by End Market

The following table summarizes revenue by end market. The categorization of revenue by end market is determined using a variety of data points including the technical characteristics of the product, the “sold to” customer information, the “ship to” customer information and the end customer product or application into which the Company’s product will be incorporated. As data systems for capturing and tracking this data and the Company's methodology evolves and improves, the categorization of products by end market can vary over time. When this occurs, the Company reclassifies revenue by end market for prior periods. Such reclassifications typically do not materially change the sizing of, or the underlying trends of revenue within, each end market.

			Three Months Ended
			January 28, 2023																		January 29, 2022
			Revenue						% of Revenue*						Y/Y%						Revenue						% of Revenue*
Industrial			$	1,690,202					52		%				26		%				$	1,340,284					50		%
Automotive			718,165						22		%				29		%				557,634						21		%
Communications			487,986						15		%				18		%				412,754						15		%
Consumer			353,277						11		%				(5)		%				373,621						14		%
Total revenue			$	3,249,630					100		%				21		%				$	2,684,293					100		%
* The sum of the individual percentages may not equal the total due to rounding.

Revenue by Sales Channel

The following table summarizes revenue by channel. The Company sells its products globally through a direct sales force, third party distributors, independent sales representatives and via its website. Distributors are customers that buy products with the intention of reselling them. Direct customers are non-distributor customers and consist primarily of original equipment manufacturers. Other customers include the U.S. government, government prime contractors and certain commercial customers for which revenue is recorded over time.

			Three Months Ended
			January 28, 2023												January 29, 2022
Channel			Revenue						% of Revenue*						Revenue						% of Revenue*
Distributors			$	2,011,323					62		%				$	1,653,054					62		%
Direct customers			1,195,534						37		%				1,003,181						37		%
Other			42,773						1		%				28,058						1		%
Total revenue			$	3,249,630					100		%				$	2,684,293					100		%
* The sum of the individual percentages may not equal the total due to rounding.

Note 8 – Fair Value

The tables below, set forth by level, presents the Company’s financial assets and liabilities, excluding accrued interest components that were accounted for at fair value on a recurring basis as of January 28, 2023 and October 29, 2022. The tables exclude cash on hand and assets and liabilities that are measured at historical cost or any basis other than fair value. As of

8

---

January 28, 2023 and October 29, 2022, the Company held $702.6 million and $1,016.0 million, respectively, of cash that was excluded from the tables below.

			January 28, 2023
			Fair Value measurement at Reporting Date using:
			Quoted Prices in Active Markets for Identical Assets (Level 1)						Significant Other Observable Inputs (Level 2)												Total
Assets
Cash equivalents:
Available-for-sale:
Government and institutional money market funds			$	967,897					$	—											$	967,897
Other assets:
Deferred compensation plan investments			70,236						—												70,236
Forward foreign currency exchange contracts			—						15,099												15,099
Total assets measured at fair value			$	1,038,133					$	15,099											$	1,053,232
Liabilities
Interest rate derivatives (1)			$	—					$	5,078											$	5,078
Total liabilities measured at fair value			$	—					$	5,078											$	5,078

(1)The carrying value of the related debt was adjusted by an equal and offsetting amount. The fair value of interest rate derivatives is estimated using a discounted cash flow analysis based on the contractual terms of the derivatives. See Note 9, Derivatives, in these Notes to Condensed Consolidated Financial Statements.

			October 29, 2022
			Fair Value measurement at Reporting Date using:
			Quoted Prices in Active Markets for Identical Assets (Level 1)						Significant Other Observable Inputs (Level 2)												Total
Assets
Cash equivalents:
Available-for-sale:
Government and institutional money market funds			$	454,545					$	—											$	454,545
Other assets:
Deferred compensation plan investments			63,211						—												63,211
Total assets measured at fair value			$	517,756					$	—											$	517,756
Liabilities
Forward foreign currency exchange contracts			$	—					$	16,984											$	16,984
Total liabilities measured at fair value			$	—					$	16,984											$	16,984

Assets and Liabilities Not Recorded at Fair Value on a Recurring Basis

Debt — The table below presents the estimated fair value of certain financial instruments not recorded at fair value on a recurring basis. The fair values of the senior unsecured notes are obtained from broker prices and are classified as Level 1 measurements according to the fair value hierarchy.

9

---

			January 28, 2023												October 29, 2022
			Principal Amount Outstanding						Fair Value						Principal Amount Outstanding						Fair Value
2024 Notes, due October 2024			$	500,000					$	493,553					$	500,000					$	491,982
2025 Notes, due April 2025			400,000						387,653						400,000						383,378
2026 Notes, due December 2026			900,000						873,065						900,000						851,479
Maxim 2027 Notes, due June 2027			59,788						56,272						59,788						54,771
2027 Notes, due June 2027			440,212						423,393						440,212						410,091
2028 Notes, due October 2028			750,000						652,779						750,000						621,093
2031 Notes, due October 2031			1,000,000						839,410						1,000,000						786,772
2032 Notes, due October 2032			300,000						293,118						300,000						278,359
2036 Notes, due December 2036			144,278						136,279						144,278						126,274
2041 Notes, due October 2041			750,000						582,974						750,000						513,709
2045 Notes, due December 2045			332,587						346,169						332,587						313,931
2051 Notes, due October 2051			1,000,000						731,707						1,000,000						640,766
Total debt			$	6,576,865					$	5,816,372					$	6,576,865					$	5,472,605

Note 9 – Derivatives

Foreign Exchange Exposure Management — The total notional amounts of forward foreign currency derivative instruments designated as hedging instruments of cash flow hedges denominated in Euros, British Pounds, Philippine Pesos, Thai Baht, South Korean Won and Japanese Yen as of January 28, 2023 and October 29, 2022 were $310.3 million and $307.1 million, respectively. The fair values of forward foreign currency derivative instruments designated as hedging instruments in the Company’s Condensed Consolidated Balance Sheets as of January 28, 2023 and October 29, 2022 were as follows:

									Fair Value At
			Balance Sheet Location						January 28, 2023						October 29, 2022
Forward foreign currency exchange contracts			Prepaid expenses and other current assets						$	8,631					$	—
Forward foreign currency exchange contracts			Accrued liabilities						$	—					$	18,050

As of January 28, 2023 and October 29, 2022, the total notional amounts of undesignated hedges related to forward foreign currency exchange contracts were $334.9 million and $246.4 million, respectively.

The following table presents the gross amounts of the Company's forward foreign currency exchange contract derivative assets and liabilities and the net amounts recorded in the Company's Condensed Consolidated Balance Sheets:

			January 28, 2023						October 29, 2022
Gross amounts of recognized liabilities			$	(1,815)					$	(19,846)
Gross amount of recognized assets			16,914						2,862
Net assets (liabilities) presented in the Condensed Consolidated Balance Sheets			$	15,099					$	(16,984)

Interest Rate Exposure Management — The Company's current and future debt may be subject to interest rate risk. The Company utilizes interest rate derivatives to alter interest rate exposure in an attempt to reduce the effects of changes in interest rates. During fiscal 2023, the Company entered into interest rate swap transactions related to its outstanding $1,000.0 million aggregate principal amount of 2.1% senior unsecured notes (the 2031 Notes) where the Company swapped the notional amount of its $1,000.0 million of fixed rate debt at 2.1% into floating interest rate debt through April 1, 2031. The fair value of the swaps at inception was zero and subsequent changes in the fair value of the interest rate swaps were reflected in the carrying value of the interest rate swaps on the balance sheet. The carrying value of the debt on the balance sheet was adjusted by an equal and offsetting amount. The interest rate swaps were designated and qualified as fair value hedges. The Company does not consider the risk of counterparty default to be significant. The gain or loss on the hedged item attributable to the hedged benchmark interest rate risk and the offsetting gain or loss on the related interest rate swaps were recorded as follows:

10

---

						January 28, 2023
Balance Sheet location						Loss on Swaps						Gain on Note
Accrued liabilities						$	5,078					$	—
Long term debt						$	—					$	5,078

For information on the unrealized holding gains (losses) on derivatives included in and reclassified out of AOCI into the Condensed Consolidated Statements of Income related to forward foreign currency exchange contracts, see Note 3, Accumulated Other Comprehensive (Loss) Income, in these Notes to Condensed Consolidated Financial Statements for further information.

Note 10 – Inventories

Inventories at January 28, 2023 and October 29, 2022 were as follows:

			January 28, 2023						October 29, 2022
Raw materials			$	118,737					$	110,908
Work in process			948,201						904,648
Finished goods			456,004						384,358
Total inventories			$	1,522,942					$	1,399,914

Note 11 – Debt

On June 23, 2021, the Company entered into a Third Amended and Restated Credit Agreement (Revolving Credit Agreement) with Bank of America, N.A. as administrative agent and the other banks identified therein as lenders. The Revolving Credit Agreement provides for a five year unsecured revolving credit facility in an aggregate principal amount not to exceed $2.5 billion (subject to certain terms and conditions).

In the first quarter of fiscal 2023, the Company amended the Revolving Credit Agreement, replacing the LIBOR interest rate provisions with interest rate provisions based on a forward-looking term rate based on the secured overnight financing rate (SOFR) plus a 10 basis point credit spread adjustment. After the amendment, revolving loans under the Revolving Credit Agreement can be Term SOFR Loans or Base Rate Loans (each as defined in the Revolving Credit Agreement, as amended) at the Company's option. Each Term SOFR Loan will bear interest at a rate per annum equal to the applicable adjusted term SOFR plus a margin based on the Company's Debt Ratings (as defined in the Revolving Credit Agreement, as amended) from time to time of between 0.690% and 1.175%. As of January 28, 2023, the Company had no outstanding borrowings under this revolving credit facility but may borrow in the future and use the proceeds for repayment of existing indebtedness, stock repurchases, acquisitions, capital expenditures, working capital and other lawful corporate purposes.

Note 12 – Income Taxes

The Company’s effective tax rates for the three-month periods ended January 28, 2023 and January 29, 2022 were below the U.S. statutory tax rate of 21.0%, due to lower statutory tax rates applicable to the Company's operations in the foreign jurisdictions in which it earns income. The Company's effective tax rate also includes the effects of the mandatory capitalization and amortization of research and development expenses which began in fiscal 2023 under the Tax Cuts and Jobs Act of 2017. The mandatory capitalization requirement decreases the Company's effective tax rate primarily by increasing the foreign-derived intangible income deduction.

It is reasonably possible that the balance of gross unrealized tax benefits, including accrued interest and penalties, could decrease by as much as $129.0 million within the next twelve months due to the completion of tax audits, including any administrative appeals.

The Company has numerous audits ongoing throughout the world including: an IRS income tax audit for the fiscal years ended November 3, 2018 and November 2, 2019; a pre-acquisition IRS income tax audit for Maxim's fiscal years ended June 27, 2015 through August 26, 2021; various U.S. state and local audits and various international audits. The Company's U.S. federal income tax returns prior to the fiscal year ended November 3, 2018 are no longer subject to examination, except for the applicable Maxim pre-acquisition fiscal years noted above.

11

---

Note 13 – New Accounting Pronouncements

Standards to Be Implemented

Acquired Contract Assets and Contract Liabilities

In October 2021, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2021-08, Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities. Under the new guidance (ASC 805-20-30-28), the acquirer should determine what contract assets and/or contract liabilities it would have recorded under ASC 606 (the revenue guidance) as of the acquisition date, as if the acquirer had entered into the original contract at the same date and on the same terms as the acquiree. The recognition and measurement of those contract assets and contract liabilities will likely be comparable to what the acquiree has recorded on its books under ASC 606 as of the acquisition date. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. ASU 2021-08 is effective for the Company in the first quarter of the fiscal year ended November 2, 2024. Early adoption is permitted, including in an interim period, for any period for which financial statements have not yet been issued. However, adoption in an interim period other than the first fiscal quarter requires an entity to apply the new guidance to all prior business combinations that have occurred since the beginning of the annual period in which the new guidance is adopted. The Company is currently evaluating the adoption date of ASU 2021-08 and the impact, if any, adoption will have on its financial position and results of operations.

Note 14 – Subsequent Events

On February 14, 2023, the Board of Directors of the Company declared a cash dividend of $0.86 per outstanding share of common stock. The dividend will be paid on March 8, 2023 to all shareholders of record at the close of business on February 27, 2023 and is expected to total approximately $435.0 million.

12

---

ITEM 2.			Management’s Discussion and Analysis of Financial Condition and Results of Operations

This information should be read in conjunction with the unaudited condensed consolidated financial statements and related notes included in Part I, Item 1 of this Quarterly Report on Form 10-Q and the audited consolidated financial statements and related notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended October 29, 2022 (fiscal 2022).

This Quarterly Report on Form 10-Q, including the following discussion, contains forward-looking statements regarding future events and our future results that are subject to the safe harbor created under the Private Securities Litigation Reform Act of 1995 and other safe harbors under the Securities Act of 1933 and the Securities Exchange Act of 1934. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the industries in which we operate and the beliefs and assumptions of our management. Words such as “expects,” “anticipates,” “targets,” “goals,” “projects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “continues,” “may,” “could” and “will,” and variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, any statements that refer to projections regarding our future financial performance; our anticipated growth and trends in our businesses; the effects of business, economic, political, legal, and regulatory impacts or conflicts upon our global operations; changes in demand for semiconductors and the related changes in demand and supply for our products; manufacturing delays, product availability, and supply chain disruptions; our ability to recruit or retain our key personnel; our future liquidity, capital needs and capital expenditures; our development of technologies and research and development investments; our future market position and expected competitive changes in the marketplace for our products; the anticipated result of litigation matters; our plans to pay dividends or repurchase stock; servicing our outstanding debt; our plans to borrow under our Revolving Credit Agreement and planned use of proceeds from such borrowing; our expected tax rate; the effect of changes in or the application of new or revised tax laws; expected cost savings; the effect of new accounting pronouncements; our plans to integrate or realize the benefits or synergies expected of acquired businesses and technologies, including the acquired business, operations and employees of Maxim Integrated Products, Inc.; our continued initiatives to consolidate our footprint related to our business units including our manufacturing, engineering, sales, marketing and administrative offices; and other characterizations of future events or circumstances are forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Important factors that could cause actual results to differ materially from those in these forward-looking statements include the risk factors included in Part I, Item 1A, "Risk Factors" of our Annual Report on Form 10-K for fiscal 2022 and, if applicable, those included under Part II, Item 1A of this Quarterly Report on Form 10-Q.

Results of Operations

Overview

(all tabular amounts in thousands except per share amounts and percentages)

			Three Months Ended
			January 28, 2023						January 29, 2022						$ Change						% Change
Revenue			$	3,249,630					$	2,684,293					$	565,337					21		%
Gross margin %			65.4		%				52.2		%
Net income			$	961,474					$	280,077					$	681,397					243		%
Net income as a % of revenue			29.6		%				10.4		%
Diluted EPS			$	1.88					$	0.53					$	1.35					255		%

Revenue Trends by End Market

The following table summarizes revenue by end market. The categorization of revenue by end market is determined using a variety of data points including the technical characteristics of the product, the “sold to” customer information, the “ship to” customer information and the end customer product or application into which our product will be incorporated. As data systems for capturing and tracking this data and our methodology evolves and improves, the categorization of products by end market can vary over time. When this occurs, we reclassify revenue by end market for prior periods. Such reclassifications typically do not materially change the sizing of, or the underlying trends of revenue within, each end market.

13

---

			Three Months Ended
			January 28, 2023																		January 29, 2022
			Revenue						% of Revenue*						Y/Y%						Revenue						% of Revenue*
Industrial			$	1,690,202					52		%				26		%				$	1,340,284					50		%
Automotive			718,165						22		%				29		%				557,634						21		%
Communications			487,986						15		%				18		%				412,754						15		%
Consumer			353,277						11		%				(5)		%				373,621						14		%
Total revenue			$	3,249,630					100		%				21		%				$	2,684,293					100		%
* The sum of the individual percentages may not equal the total due to rounding.

Revenue increased 21% in the three-month period ended January 28, 2023, as compared to the same period of the prior fiscal year, primarily as a result of broad-based demand for our products sold into the Industrial, Automotive and Communications end markets, partially offset by a decrease in revenue in the Consumer end market primarily due to weakening market trends.

Revenue by Sales Channel

The following table summarizes revenue by sales channel. We sell our products globally through a direct sales force, third party distributors, independent sales representatives and via our website. Distributors are customers that buy products with the intention of reselling them. Direct customers are non-distributor customers and consist primarily of original equipment manufacturers. Other customers include the U.S. government, government prime contractors and certain commercial customers for which revenue is recorded over time.

			Three Months Ended
			January 28, 2023												January 29, 2022
			Revenue						% of Revenue*						Revenue						% of Revenue*
Channel
Distributors			$	2,011,323					62		%				$	1,653,054					62		%
Direct customers			1,195,534						37		%				1,003,181						37		%
Other			42,773						1		%				28,058						1		%
Total revenue			$	3,249,630					100		%				$	2,684,293					100		%
* The sum of the individual percentages may not equal the total due to rounding.

As indicated in the table above, the percentage of total revenue sold via each channel has remained relatively consistent in the periods presented, but can fluctuate from time to time based on end customer demand.

Gross Margin

			Three Months Ended
			January 28, 2023						January 29, 2022						$ Change						% Change
Gross margin			$	2,124,341					$	1,401,997					$	722,344					52		%
Gross margin %			65.4		%				52.2		%

Gross margin percentage increased by 1,320 basis points in the three-month period ended January 28, 2023, as compared to the same period of the prior fiscal year primarily as a result of additional cost of goods sold of $271.4 million related to a nonrecurring fair value adjustment recorded to inventory as a result of the acquisition of Maxim Integrated Products, Inc. (Maxim) included in the three-month period ended January 29, 2022. The remainder of the increase primarily related to favorable product mix and synergies related to the acquisition of Maxim.

Research and Development (R&D)

			Three Months Ended
			January 28, 2023						January 29, 2022						$ Change						% Change
R&D expenses			$	414,095					$	426,780					$	(12,685)					(3)		%
R&D expenses as a % of revenue			13		%				16		%

14

---

R&D expenses decreased in the three-month period ended January 28, 2023, as compared to the same period of the prior fiscal year, primarily as a result of lower salary and benefit expenses and lower discretionary spending, partially offset by higher R&D employee-related variable compensation expenses.

R&D expenses as a percentage of revenue will fluctuate from year-to-year depending on the amount of revenue and the success of new product development efforts, which we view as critical to our future growth. We expect to continue the development of innovative technologies and processes for new products. We believe that a continued commitment to R&D is essential to maintain product leadership with our existing products as well as to provide innovative new product offerings.

Selling, Marketing, General and Administrative (SMG&A)

			Three Months Ended
			January 28, 2023						January 29, 2022						$ Change						% Change
SMG&A expenses			$	326,284					$	297,365					$	28,919					10		%
SMG&A expenses as a % of revenue			10		%				11		%

SMG&A expenses increased in the three-month period ended January 28, 2023, as compared to the same period of the prior fiscal year, primarily as a result of higher variable compensation expenses, salary and benefit expenses and discretionary spending, partially offset by lower acquisition-related transaction costs.

Amortization of Intangibles

			Three Months Ended
			January 28, 2023						January 29, 2022						$ Change						% Change
Amortization expenses			$	253,142					$	253,367					$	(225)					—		%
Amortization expenses as a % of revenue			8		%				9		%

Amortization expenses were relatively flat in the three-month period ended January 28, 2023, as compared to the same period of the prior fiscal year.

Special Charges, Net

			Three Months Ended
			January 28, 2023						January 29, 2022						$ Change						% Change
Special charges, net			$	—					$	59,728					$	(59,728)					n/a
Special charges, net as a % of revenue			—		%				2		%

Special charges, net decreased in the three-month period ended January 28, 2023, as compared to the same period of the prior fiscal year, primarily as a result of charges recorded in the first quarter of fiscal 2022 as part of the integration of Maxim and continued organizational initiatives to better align our global workforce with our long-term strategic plan.

Operating Income

			Three Months Ended
			January 28, 2023						January 29, 2022						$ Change						% Change
Operating income			$	1,130,820					$	364,757					$	766,063					210		%
Operating income as a % of revenue			34.8		%				13.6		%

The year-over-year increase in operating income in the three-month period ended January 28, 2023 was primarily the result of an increase in revenue of $565.3 million, which contributed to an increase in gross margin of $722.3 million, and decreases of $59.7 million in special charges, net and $12.7 million in R&D expenses, offset by an increase of $28.9 million in SMG&A expenses.

15

---

Nonoperating Expense (Income)

			Three Months Ended
			January 28, 2023						January 29, 2022						$ Change
Total nonoperating expense (income)			$	57,347					$	41,202					$	16,145

The year-over-year increase in nonoperating expense (income) in the three-month period ended January 28, 2023 as compared to the same period of the prior year was the result of higher interest expense related to our debt obligations and lower net gains from other investments.

Provision for Income Taxes

			Three Months Ended
			January 28, 2023						January 29, 2022						$ Change
Provision for income taxes			$	111,999					$	43,478					$	68,521
Effective income tax rate			10.4		%				13.4		%

The effective tax rates for the three-month periods ended January 28, 2023 and January 29, 2022 were below the U.S. statutory tax rate of 21% due to lower statutory tax rates applicable to our operations in the foreign jurisdictions in which we earn income. Our pretax income for the three-month periods ended January 28, 2023 and January 29, 2022 was primarily generated in Ireland at a tax rate of 12.5%. The Company's effective tax rate for the three-month period ended January 28, 2023 also includes the effects of the mandatory capitalization and amortization of research and development expenses which began in fiscal 2023 under the 2017 Tax Cuts and Jobs Act. The mandatory capitalization requirement decreased our effective tax rate primarily by increasing the foreign-derived intangible income deduction.

See Note 12, Income Taxes, in the Notes to Condensed Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report on Form 10-Q for further discussion.

Net Income

			Three Months Ended
			January 28, 2023						January 29, 2022						$ Change						% Change
Net Income			$	961,474					$	280,077					$	681,397					243		%
Net Income as a % of revenue			29.6		%				10.4		%
Diluted EPS			$	1.88					$	0.53

Net income increased in the three-month period ended January 28, 2023, as compared to the same period of the prior fiscal year, as a result of a $766.1 million increase in operating income, partially offset by a $68.5 million increase in provision for income taxes and a $16.1 million increase in nonoperating expense (income).

Liquidity and Capital Resources

At January 28, 2023, our principal source of liquidity was $1,670.5 million of cash and cash equivalents, of which approximately $386.6 million was held in the United States and the balance of our cash and cash equivalents was held outside the United States in various foreign subsidiaries. We manage our worldwide cash requirements by, among other things, reviewing available funds held by our foreign subsidiaries and the cost effectiveness by which those funds can be accessed in the United States. We do not expect current regulatory restrictions or taxes on repatriation to have a material adverse effect on our overall liquidity, financial condition or the results of operations. Our cash and cash equivalents consist of highly liquid investments with maturities of three months or less, including money market funds. We maintain these balances with high credit quality counterparties, continually monitor the amount of credit exposure to any one issuer and diversify our investments in order to minimize our credit risk.

16

---

We believe that our existing sources of liquidity and cash expected to be generated from future operations, together with existing and anticipated available short- and long-term financing, will be sufficient to fund operations, capital expenditures, research and development efforts and dividend payments (if any) in the immediate future and for at least the next twelve months.

			Three Months Ended
			January 28, 2023						January 29, 2022
Net cash provided by operating activities			$	1,406,305					$	856,413
Net cash provided by operations as a % of revenue			43		%				32		%
Net cash used for investing activities			$	(176,056)					$	(103,309)
Net cash used for financing activities			$	(1,030,359)					$	(937,268)

The following changes contributed to the net change in cash and cash equivalents in the three-month period ended January 28, 2023 as compared to the same period in fiscal 2022.

Operating Activities

Cash provided by operating activities is net income adjusted for certain non-cash items and changes in operating assets and liabilities. The increase in cash provided by operating activities during the three-month period ended January 28, 2023, as compared to the same period of the prior fiscal year, was the result of higher net income adjusted for noncash items offset by changes in working capital.

Investing Activities

Investing cash flows generally consist of capital expenditures and cash used for acquisitions. The increase in cash used for investing activities during the three-month period ended January 28, 2023, as compared to the same period of the prior fiscal year, was primarily the result of an increase in cash used for capital expenditures.

Financing Activities

Financing cash flows generally consist of payments of dividends to stockholders, repurchases of common stock, issuance and repayment of debt and proceeds from the sale of shares of common stock pursuant to employee equity incentive plans. The increase in cash used for financing activities during the three-month period ended January 28, 2023, as compared to the same period of the prior fiscal year, was primarily the result of higher common stock repurchases partially offset by the early termination of debt in the first quarter of fiscal 2022.

Working Capital

			January 28, 2023						October 29, 2022						$ Change						% Change
Accounts receivable			$	1,629,870					$	1,800,462					$	(170,592)					(9)		%
Days sales outstanding*			48						50
Inventory			$	1,522,942					$	1,399,914					$	123,028					9		%
Days cost of sales in inventory*			118						107

_______________________________________

*We use the average of the current quarter and prior quarter ending net accounts receivable and ending inventory balance in our calculation of days sales outstanding and days cost of sales in inventory, respectively. Cost of sales amounts used in the calculation of days cost of sales in inventory include accounting adjustments related to amortization of developed technology intangible assets acquired and depreciation related to the write-up of fixed assets to fair value as a result of the acquisition of Maxim.

The decrease in accounts receivable in dollars was primarily the result of variations in the timing of collections and billings.

Inventory increased primarily as a result of our efforts to balance manufacturing production, demand and inventory levels. Our inventory levels are impacted by our need to support forecasted sales demand and variations between those forecasts and actual demand.

Current liabilities were relatively flat at approximately $2,433.7 million at January 28, 2023 and approximately $2,442.7 million at the end of fiscal 2022. This was due to higher income taxes payable offset by lower accrued liabilities and accounts payable.

17

---

Debt

As of January 28, 2023, our debt obligations consisted of the following:

						Principal Amount Outstanding
2024 Notes, due October 2024						$	500,000
2025 Notes, due April 2025						400,000
2026 Notes, due December 2026						900,000
Maxim 2027 Notes, due June 2027						59,788
2027 Notes, due June 2027						440,212
2028 Notes, due October 2028						750,000
2031 Notes, due October 2031						1,000,000
2032 Notes, due October 2032						300,000
2036 Notes, due December 2036						144,278
2041 Notes, due October 2041						750,000
2045 Notes, due December 2045						332,587
2051 Notes, due October 2051						1,000,000
Total debt						$	6,576,865

The indentures governing our outstanding notes contain covenants that may limit our ability to: incur, create, assume or guarantee any debt for borrowed money secured by a lien upon a principal property; enter into sale and lease-back transactions with respect to a principal property; and consolidate with or merge into, or transfer or lease all or substantially all of our assets to, any other party. As of January 28, 2023, we were in compliance with these covenants.

Revolving Credit Facility

Our Third Amended and Restated Revolving Credit Agreement, dated as of June 23, 2021 and as amended, provides for a five year unsecured revolving credit facility in an aggregate principal amount not to exceed $2.5 billion (subject to certain terms and conditions).

We may borrow under this revolving credit facility in the future and use the proceeds for repayment of existing indebtedness, stock repurchases, acquisitions, capital expenditures, working capital and other lawful corporate purposes. The terms of the Revolving Credit Agreement impose restrictions on our ability to undertake certain transactions, to create certain liens on assets and to incur certain subsidiary indebtedness. In addition, the Revolving Credit Agreement contains a consolidated leverage ratio covenant of total consolidated funded debt to consolidated earnings before interest, taxes, depreciation, and amortization (EBITDA) of not greater than 3.5 to 1.0. As of January 28, 2023, we were in compliance with these covenants.

Stock Repurchase Program

In the aggregate, our Board of Directors has authorized us to repurchase $16.7 billion of our common stock under our common stock repurchase program. Unless terminated earlier by resolution of our Board of Directors, the repurchase program will expire when we have repurchased all shares authorized under the program. As of January 28, 2023, an additional $4.3 billion remains available for repurchase under the current authorized program. The repurchased shares are held as authorized but unissued shares of common stock. We also repurchase shares in settlement of employee tax withholding obligations due upon the vesting of restricted stock units/awards or the exercise of stock options as well as for our employee stock purchase plan. Future repurchases of common stock will be dependent upon our financial position, results of operations, outlook, liquidity, and other factors we deem relevant.

18

---

Capital Expenditures

Net additions to property, plant and equipment were $176.2 million in the first three months of fiscal 2023 and were funded with a combination of cash on hand and cash generated from operations. We expect capital expenditures for fiscal 2023 to be between approximately 6% and 8% of revenue, which is above our historical levels primarily due to our plans to expand internal manufacturing capacity. These capital expenditures will be funded with a combination of cash on hand and cash expected to be generated from future operations, together with existing and anticipated available short- and long-term financing.

Dividends

On February 14, 2023, our Board of Directors declared a cash dividend of $0.86 per outstanding share of common stock. The dividend will be paid on March 8, 2023 to all shareholders of record at the close of business on February 27, 2023 and is expected to total approximately $435.0 million. We currently expect quarterly dividends to continue in future periods. The payment of any future quarterly dividends, or a future increase in the quarterly dividend amount, will be at the discretion of the Board and will be dependent upon our financial position, results of operations, outlook, liquidity, and other factors deemed relevant by the Board.

Contractual Obligations

There have not been any material changes during the three-month period ended January 28, 2023 to the amounts presented in the table summarizing our contractual obligations included in our Annual Report on Form 10-K for the fiscal year ended October 29, 2022.

New Accounting Pronouncements

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board that are adopted by us as of the specified effective date. Unless otherwise discussed, management believes that the impact of recently issued standards will not have a material impact on our future financial condition and results of operations. See Note 13, New Accounting Pronouncements, in the Notes to Condensed Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report on Form 10-Q for a description of recently issued and adopted accounting pronouncements, including the dates of adoption and impact on our historical financial condition and results of operations.

Critical Accounting Policies and Estimates

There were no material changes in the three-month period ended January 28, 2023 to the information provided under the heading “Critical Accounting Policies and Estimates” in the section entitled "Management's Discussion and Analysis of Financial Condition and Results of Operations" of our Annual Report on Form 10-K for the fiscal year ended October 29, 2022.

19

---

ITEM 3.			Quantitative and Qualitative Disclosures About Market Risk

There were no material changes in the three-month period ended January 28, 2023 to the information provided under Item 7A. “Quantitative and Qualitative Disclosures about Market Risk,” set forth in our Annual Report on Form 10-K for the fiscal year ended October 29, 2022.

ITEM 4.			Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of January 28, 2023. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (Exchange Act), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of January 28, 2023, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

(b) Changes in Internal Control over Financial Reporting. No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the quarter ended January 28, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

20

---

PART II — OTHER INFORMATION

ITEM 1.			Legal Proceedings

The information required by this Item is provided in Note 6, Commitments and Contingencies of the Notes to Condensed Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report on Form 10-Q.

ITEM 1A.			Risk Factors

We are subject to a number of risks that could adversely affect our business, results of operations financial condition and future prospects including those identified in Part I, Item 1A, "Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended October 29, 2022, which was filed with the Securities and Exchange Commission on November 22, 2022.

21

---

ITEM 2.			Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities 

Period			Total Number of Shares Purchased (a)						Average Price Paid Per Share (b)						Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (c)						Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
October 30, 2022 through November 26, 2022			1,935,671						$	155.57					1,894,600						$	4,635,283,106
November 27, 2022 through December 24, 2022			1,148,599						$	166.87					1,133,500						$	4,446,129,504
December 25, 2022 through January 28, 2023			976,588						$	164.43					957,300						$	4,288,770,393
Total			4,060,858						$	160.90					3,985,400						$	4,288,770,393

(a)Includes 75,458 shares withheld by us from employees to satisfy minimum employee tax obligations upon vesting of restricted stock units/awards granted to our employees under our equity compensation plans.

(b)The average price paid for shares in connection with vesting of restricted stock units/awards are averages of the closing stock price at the vesting date which is used to calculate the number of shares to be withheld.

(c)Shares repurchased pursuant to the stock repurchase program publicly announced on August 12, 2004 and updated thereafter. Under the repurchase program, we may repurchase outstanding shares of our common stock from time to time in the open market and through privately negotiated transactions in an aggregate amount of up to $16.7 billion. Unless terminated earlier by resolution of our Board of Directors, the repurchase program will expire when we have repurchased all shares authorized for repurchase under the repurchase program.

22

---

ITEM 6.			Exhibits

Exhibit No.						Description
3.1						Amended and Restated Bylaws of Analog Devices, Inc., filed as exhibit 3.1 to the Company's Current Report on Form 8-K (File No. 1-7819) as filed with the Commission on December 8, 2022 and incorporated herein by reference.
10.1†						Amendment No. 1 to Third Amended And Restated Credit Agreement dated December 20, 2022.
#10.2†						Form of Global Non-Qualified Stock Option Agreement for usage under the Company's Amended and Restated 1996 Stock Incentive Plan adopted December 5, 2022.
#10.3†						Form of Global Restricted Stock Unit Agreement for Employees for usage under the Company’s Amended and Restated 1996 Stock Incentive Plan adopted December 5, 2022.
#10.4†						Form of Global Non-Qualified Stock Option Agreement for Employees for usage under the Company’s 2020 Equity Incentive Plan adopted December 5, 2022.
#10.5†						Form of Global Restricted Stock Unit Agreement for Employees for usage under the Company’s 2020 Equity Incentive Plan adopted December 5, 2022.
#10.6†						Form of Restricted Stock Unit Agreement for Non-Employee Directors for usage under the Company’s 2020 Equity Incentive Plan adopted December 5, 2022.
#10.7†						Form of Financial Metric Performance Restricted Stock Unit Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan adopted December 5, 2022.
#10.8†						Form of Relative Total Shareholder Return Performance Restricted Stock Unit Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan adopted December 5, 2022.
#10.9†						RSU Equity Award Conversion Agreement.
#10.10						Maxim Integrated Products Form of Global Restricted Stock Unit Agreement effective July 12, 2020, filed as exhibit 10.28 to Maxim Integrated Products, Inc.'s Annual Report on Form 10-K for the fiscal year ended June 27, 2020 (File No. 1-34192) as filed with the Commission on August 19, 2020 and incorporated herein by reference.
#10.11†						RSA Equity Award Conversion Agreement.
#10.12						Maxim Integrated Products, Inc. Form of Global Restricted Stock Agreement, filed as exhibit 10.5 to Maxim Integrated Products, Inc.'s Quarterly Report on Form 10-Q for the fiscal quarter ended September 26, 2020 (File No. 1-34192) as filed with the Commission on October 28, 2020 and incorporated herein by reference.
#10.13†						MSU Equity Award Conversion Agreement.
#10.14						Maxim Integrated Products, Inc. Form of Global Performance Share Agreement for September 2019 Grants, filed as exhibit 10.1 to Maxim Integrated Products, Inc.'s Quarterly Report on Form 10-Q for the fiscal quarter ended September 28, 2019 (File No. 1-34192) as filed with the Commission on October 30, 2019 and incorporated herein by reference.
#10.15†						Form of Performance Restricted Stock Unit Agreement – 2021 Integration Award.
31.1†						Certification Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Chief Executive Officer).
31.2†						Certification Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Chief Financial Officer).
32.1†*						Certification Pursuant to 18 U.S.C. Section 1350 (Chief Executive Officer).
32.2†*						Certification Pursuant to 18 U.S.C. Section 1350 (Chief Financial Officer).
101.INS						The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the inline XBRL document.**
101.SCH						Inline XBRL Schema Document.**
101.CAL						Inline XBRL Calculation Linkbase Document.**
101.LAB						Inline XBRL Labels Linkbase Document.**
101.PRE						Inline XBRL Presentation Linkbase Document.**
101.DEF						Inline XBRL Definition Linkbase Document.**
104						Cover page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101).
†						Filed or furnished herewith.
#						Indicates management contract or compensatory plan, contract or agreement.

23

---

*						The certification furnished in each of Exhibits 32.1 and 32.2 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates each by reference. Such certification will not be deemed to be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference.
**						Submitted electronically herewith.

Attached as Exhibit 101 to this report are the following formatted in iXBRL (Inline Extensible Business Reporting Language): (i) Condensed Consolidated Statements of Income for the three months ended January 28, 2023 and January 29, 2022, (ii) Condensed Consolidated Statements of Comprehensive Income for the three months ended January 28, 2023 and January 29, 2022, (iii) Condensed Consolidated Balance Sheets at January 28, 2023 and October 29, 2022, (iv) Condensed Consolidated Statements of Shareholders' Equity for the three months ended January 28, 2023 and January 29, 2022, (v) Condensed Consolidated Statements of Cash Flows for the three months ended January 28, 2023 and January 29, 2022 and (vi) Notes to Condensed Consolidated Financial Statements for the three months ended January 28, 2023.

24

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

			ANALOG DEVICES, INC.
Date: February 15, 2023			By:						/s/ Vincent Roche
									Vincent Roche
									Chief Executive Officer and Chair of the Board of Directors
									(Principal Executive Officer)
Date: February 15, 2023			By:						/s/ Prashanth Mahendra-Rajah
									Prashanth Mahendra-Rajah
									Executive Vice President, Finance and Chief Financial Officer
									(Principal Financial Officer)

25

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---